메뉴 건너뛰기




Volumn 65, Issue 6, 2000, Pages 379-389

Treatment outcome in patients younger than 60 years with advanced stages (IIB-IV) of Hodgkin's disease: The Swedish National Heath Care Programme experience

Author keywords

Advanced stages; Hodgkin's disease; Prognostic factors; Treatment

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; PREDNIMUSTINE; PREDNISONE; PROCARBAZINE; SERUM ALBUMIN; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

EID: 0033665426     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.065006379.x     Document Type: Article
Times cited : (18)

References (27)
  • 3
    • 0031961809 scopus 로고    scopus 로고
    • MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: The 8-year results of the intergroup trial
    • (1998) J Clin Oncol , vol.16 , pp. 19-26
    • Glick, J.H.1    Young, M.L.2    Harrington, D.3
  • 8
    • 0028800924 scopus 로고
    • Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease
    • (1995) Ann Oncol , vol.6 , pp. 901-910
    • Diehl, V.1    Loeffler, M.2    Pfreundschuh, U.3
  • 10
    • 0029836645 scopus 로고    scopus 로고
    • Hodgkin's disease - The role of radiation therapy in advanced disease
    • (1996) Ann Oncol , vol.7 , pp. 99-103
    • Hoppe, R.T.1
  • 14
    • 8244252277 scopus 로고    scopus 로고
    • Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: Interim results from the ongoing EORTC-LCG and GPMC phase III trial
    • (1997) Ann Oncol , vol.8 , pp. 111-114
    • Raemaekers, J.1    Burgers, M.2    Henry-Amar, M.3
  • 20
    • 0023264243 scopus 로고
    • Risk of therapy-related leukemia and preleukemia after Hodgkin's disease: Relation to age, cumulative dose of alkylating agents, and time from chemotherapy
    • (1987) Lancet , vol.7 , pp. 83-88
    • Pedersen-Bjergaard, J.1    Specht, L.2
  • 22
    • 0032422646 scopus 로고    scopus 로고
    • BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group
    • (1998) J Clin Oncol , vol.16 , pp. 3810-3821
    • Diehl, V.1    Franklin, J.2    Hasenclever, D.3
  • 25
    • 0027444652 scopus 로고
    • A predictive model for aggressive non-Hodgkin's lymphoma
    • (1993) N Engl J Med , vol.329 , pp. 987-994


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.